hotspot -WSS

hotspot

author：focus 2025-09-29 20:50:53 - browse：2882

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare’s new pay boost for primary care is angering specialists

WSS

A letter from the executive editor: STAT UnitedHealth investigation

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Nearly two

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Gilgo Beach: Police identify another victim in serial killing investigation

focus

hotspot

leisure time

Cancer drug shortages should be causing more outrage

Gilgo Beach: Police identify another victim in serial killing investigation

Novavax promises a turnaround & Lilly roils the obesity market

Ventyx halts psoriasis drug development after lackluster trial results

After affirmative action ruling, medical educators look to 'holistic review'

Ventyx halts psoriasis drug development after lackluster trial results

Activists slam private health insurers over coverage restrictions

Experimental asthma app from Apple and Anthem shows promise

Medical leaders decry Supreme Court decision on affirmative action

TytoCare raises $49 million to build out AI

leisure time

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Publishing genetic code of viruses could cause disaster

What the cancer research community can learn from the Covid response

Dramatically reducing cancer deaths requires the PASTEUR Act

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Carbon Health diabetes program, a test of data

focus

focus

entertainment

focus